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Abstract
Negative thinking is prominent in major depressive disorder (MDD). Cognitive models propose that
negative thinking influences the hypothalamus-pituitary-adrenal axis and cortisol release. Oxytocin is also
linked to MDD, social and affective processing, and stress buffering. Little research has examined direct
relationships between negative cognitions, cortisol, and oxytocin. Methods: Sixty-one unmedicated
participants meeting DSM-5 criteria for MDD and 60 healthy controls completed measures of
psychopathology, stress, and cognitions. Plasma samples were analyzed for cortisol and oxytocin.
Between-group analyses of variance were conducted along with correlational, regression and mediation
analyses. Results: Depressed participants reported greater frequency and believability of negative
thoughts than controls. Cortisol levels were positively, and oxytocin inversely, correlated with negative
thinking. Cortisol and negative thinking accounted for unique variance in depression, and the relationship
between stress and cortisol depended on the extent of negative cognitions. Conclusions: The results
support long-standing cognitive models which propose that negative thoughts are important in the
relationship between stress and cortisol levels.
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Negative thinking is prominent in major depressive disorder (MDD). Cognitive models
propose that negative thinking inﬂuences the hypothalamus-pituitary-adrenal axis and
cortisol release. Oxytocin is also linked to MDD, social and affective processing, and stress
buffering. Little research has examined direct relationships between negative cognitions,
cortisol, and oxytocin.
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Methods: Sixty-one unmedicated participants meeting DSM-5 criteria for MDD and 60
healthy controls completed measures of psychopathology, stress, and cognitions.
Plasma samples were analyzed for cortisol and oxytocin. Between-group analyses of
variance were conducted along with correlational, regression and mediation analyses.
Results: Depressed participants reported greater frequency and believability of negative
thoughts than controls. Cortisol levels were positively, and oxytocin inversely, correlated
with negative thinking. Cortisol and negative thinking accounted for unique variance in
depression, and the relationship between stress and cortisol depended on the extent of
negative cognitions.
Conclusions: The results support long-standing cognitive models which propose that
negative thoughts are important in the relationship between stress and cortisol levels.
Keywords: cognitive distortions, cortisol, oxytocin, major depressive disorder, stress

INTRODUCTION
Cortisol dysregulation (1, 2) and pessimistic thinking styles (3, 4) are both independently strongly
linked to depression. Additionally, the oxytocinergic system is involved in affective and social
processing (5, 6), stress buffering (7), and is also related to depressive symptoms (8). While cortisol,
oxytocin, and negative thinking are all linked to depression, there is still little research examining
direct relationships between these factors.
The development, severity, and course of MDD are closely related to psychosocial stress. A key
mechanism linking stress and MDD is altered hypothalamic-pituitary-adrenal (HPA) functioning.
The HPA system allows organisms to adapt to physical and psychosocial changes in their
environments. In humans, perceived stress activates the central nervous system (CNS), which
stimulates the release of corticotropin releasing hormone (CRH) from the hypothalamus, adrenal
corticotrophic hormone (ACTH) from the anterior pituitary, and cortisol from the adrenal cortex.
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More recently, cognitive models have evolved to integrate
neurobiological, particularly brain imaging, data (4). For
example, cognitive biases in depression have been linked to
maladaptive bottom-up patterns of activation initiated in
subcortical brain regions, accompanied by impairment in the
top-down cognitive control of subcortical emotional activity by
higher-level cortical regions (18, 20). Such models propose that a
hypersensitive amygdala and hypoactive prefrontal regions are
associated with impairments in the ability to think rationally in
depression (4). This is supported by indications that when
attending to emotional stimuli, individuals with depression show
more intense and longer-lasting amygdala reactivity (21), along
with impaired attentional disengagement which is correlated with
decreased activity in the right ventro- and dorso-lateral-pre-frontal
cortical areas compared to healthy controls (22, 23). Beck proposed
a hypothetical pathway starting with genetic vulnerability, leading
to excessive amygdala reactivity and attentional deployment to
emotional stimuli, and negative information-processing biases
resulting in cognitive distortions and negative schemata. These
negative interpretations of experience trigger the hypothalamuspituitary-adrenal (HPA) axis more frequently or intensely, leading
to cortisol responses which may affect the serotonergic system and
lead to depression (4).
Over-reactions to stress, and hypercortisolemia seen in
depression have been proposed to be mediated by cognitive
distortions (4). Cognitive appraisals may modulate emotional
responses through connections from the prefrontal cortex to
limbic areas including the amygdala and hippocampus, which
are connected to the hypothalamus (24). In healthy participants,
the HPA axis can be reliably activated by psychological stress
(24). There is little research examining relationships between
patterns of negative thinking and cortisol levels in MDD. One
early study examined relationships between salivary cortisol and
negative cognition in depression over time. There were
indications that changes in negative automatic thoughts
preceded changes in cortisol, however the results were
ambiguous, and only eight participants completed the study (25).
While several lines of evidence give reason to believe that
negative cognitions, stress, and cortisol are interlinked in MDD,
there is surprisingly little direct investigation of relationships
between these key variables. Depressive symptoms, stress, and
negative cognitions are considered to be distinct concepts which
can be reliably discriminated by psychometric tools, although
they may be correlated due to shared aetiological factors such as
personality and environmental factors (26). For example, the
frequency and intensity of negative thoughts can be measured
with the Automatic Thoughts Questionnaire (ATQ; 27). Negative
cognitions correlate with measures of depression, however the
ATQ is not synonymous with depression, as depressive
symptoms include additional affective, somatic, and cognitive
factors (16), and cognitive distortions are also elevated in people
with other disorders such as anxiety, relative to controls (28). The
depression anxiety and stress scales (DASS) discriminate between
depression and stress as distinct and non-overlapping concepts,
with stress encompassing symptoms of a state of persistent
arousal and tension with a low threshold for becoming upset or

Cortisol mobilises glucose stores, to provide the organism with
energy. Cortisol affects substructures of the hippocampus and the
amygdala, reinforcing emotional encoding of the stressful
situation and potentially altering the organism's future
responses to similar stressors. Adaptive cortisol responses are
characterized by a quick rise in response to stress and a rapid
decline after the challenge has passed, achieved by negative
feedback mechanisms in the hippocampus (reviewed in 9).
HPA axis function is inﬂuenced both by genetics and by early
adverse experiences. There is well-established evidence from
animal studies that psychosocial stress, such as early separation
of non-human primates from their mothers, can lead to persistent
disturbances in the regulation of cortisol secretion (10).
Depression is associated with chronic stress and hyperactivity
of the hypothalamic-pituitary-adrenal (HPA) axis, and a
signiﬁcant percentage of depressed individuals have increased
cortisol levels (1, 2). Exposure to stress is therefore a vulnerability
factor to developing depression, which could cause impairments
to HPA functioning (11, 12).
Stress can be deﬁned as a psychophysiological response to real
or perceived pressures in the environment, including danger (13).
While adverse life events and stressors are risk factors for
developing MDD, it is not purely the power of environmental
demands which determines their emotional impact, but the
individual's psychological appraisals of their ability to cope (14).
Patterns of negative thinking are recognized as a hallmark of
depression (15) and are included in the diagnostic criteria for
major depressive disorder (16). In Beck's cognitive model of
depression (3), early adverse events, along with genetic factors,
contribute to three characteristic aspects of thinking which
perpetuate depression; the cognitive triad, schemas, and cognitive
errors. The cognitive triad consists of automatic negative thoughts
about the self (e.g. I am worthless), the world (e.g. there are
insurmountable obstacles preventing me from reaching goals), and
the future (e.g. this suffering will continue indeﬁnitely). Schemas are
long-term, stable cognitive patterns of organizing and interpreting
information, which reduce mental effort by guiding behavior in
many routine situations. However, people with depression will
often hold negative schemas following aversive early experiences
such as criticism or abuse. These dysfunctional attitudes remain
latent but are activated through stress or biological factors, leading
to information being interpreted in a pessimistic way. This in turn
leads to a number of characteristic cognitive distortions, which
have further negative impacts on mood and behavior (3).
Cognitive distortions include negative ﬁltering, where only
aspects of reality which conform to negative beliefs are attended
to, and dichotomous thinking, viewing situations in extreme
terms, where even small defects are painful. These types of
thinking represent primitive thinking styles (3) which may have
evolved as fast-track defensive forms of thinking that are adaptive
to survival in times of threat (17). Through negatively biased
information-processing, however, negative thinking can become
automatic, serving to maintain and rekindle depressive episodes
(3, 4, 18). Thus cognitive approaches to depression postulate biases
in automatic, associative forms of thinking and a failure to correct
these through slower, more reﬂective thought processes (19).
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4. Evaluate aspects of Beck's (4) hypothesis that negative cognitions mediate relationships between stress and cortisol. In
line with Beck's hypothesis, it was predicted that the relationship between stress levels and cortisol would depend on
the extent of negative cognitions.

frustrated (26). We therefore sought to measure these distinct but
related concepts in relation to cortisol and to evaluate Beck's (4)
theoretical model of relationships between them.
The oxytocinergic system is involved in a range of complex
social behaviors in humans and plays a key role in affective and
social processing and behavior (5, 6). There is evidence that
oxytocin may reduce anxiety in response to stressors by downregulating HPA axis activity, reducing amygdala reactivity (6)
and dampening stress responses (7, 29, 30). There are relatively
few studies on plasma oxytocin levels in depression, however
there is some evidence that oxytocin levels are inversely
correlated with depressive symptoms (8, 31), however a small
study (n = 11) found higher oxytocin levels in depressed than
control participants (32). It has been hypothesized that some
symptoms of depression including social withdrawal, reduced
appetite, and cognitive impairment may reﬂect central oxytocin
alterations (33). Additionally, animal studies indicate that the
oxytocinergic and HPA systems show complex independent as
well as potentially synchronized activations which are not fully
understood (e.g. 34). Investigating markers of activity of both the
HPA and oxytocinergic neuroendocrine systems in relation to
stress, depression, and cognitive distortions may help to give a
better understanding of their relative importance in MDD. One
study of healthy individuals investigated whether rumination
might function as a moderator between depressive symptoms
and oxytocin (35). It was found that high depressive symptoms
were negatively associated with oxytocin concentrations at high
but not low levels of maladaptive thinking (35), however the
study was limited by an all-male, non-clinical sample. To our
knowledge, no previous studies have investigated oxytocin levels
in relation to negative automatic thoughts in MDD. Examining
the neurobiology of negative cognitions may inform integrated
cognitive-biological models of depression, and cognitivebehavioral interventions for emotional disorders (36).

METHODS
Participants
The data were collected as part of a larger study of MDD, and the
protocol as well as mean cortisol, oxytocin, and demographic
data for this cohort have previously been reported in the context
of help-seeking (37) and quality of life (38). This study was
conducted in accordance with the recommendations of the
Australian National Statement for the Ethical Conduct of
Research. The protocol was approved by the joint health
district and university ethics committee (protocol number
2012409). All participants gave written informed consent.
Sixty-three adults were recruited who met the DSM-5
diagnostic criteria for MDD, along with 60 healthy controls.
Participants were recruited through advertisements in local
media and at the university. All participants were screened
beforehand to ensure that depressed participants likely met
DSM-5 criteria for MDD and had not taken anti-depressant
medication for at least two months, and that healthy controls had
no mental disorders or other exclusion criteria. Depressed
participants were also interviewed on arrival at the clinical
trials unit by an experienced clinical psychologist to conﬁrm
that they met diagnostic criteria for major depressive disorder
using the Mini International Neuropsychiatric Interview (39, 40)
version 7.0.2 for DSM-5, and to ascertain treatment history. All
participants were asked about any past or present mental health
problems. Exclusion criteria across groups included any
neurological disorders such as epilepsy, head injuries or
degenerative disorders as well as substance use disorders, and
use of corticosteroid medication within the last two months.

AIMS AND HYPOTHESES
The current study investigated the link between negative
cognitions, cortisol, and oxytocin in individuals with MDD.
We recruited individuals meeting diagnostic criteria for MDD
and controls with no history of MDD and collected psychometric
measures and blood samples. Speciﬁcally, we aimed to:

Measures
All participants completed the following measures: The
Depression, Anxiety and Stress Scales-21 (41), an overall
measure of psychological distress during the past seven days,
and incorporates Depression, Anxiety, and Stress subscales. The
Automatic Thoughts Questionnaire (27) is a 30-item
questionnaire which measures the frequency of occurrence of
automatic negative thoughts (negative self-statements) and
believability and strength of belief in these statements if they
occur. Respondents indicate how frequently each thought
occurred during the past week (1 = not at all, 5 = all the time),
with higher scores indicating greater frequency of negative
automatic thoughts. The ATQ has four subscales which reﬂect
aspects of these automatic thoughts: Personal maladjustment and
desire for change (PMDC), Negative self-concepts and negative
expectations (NSNE), Low self-esteem (LSE), and Helplessness.
The Total score is the sum of questions 1 to 30 and indicates the
frequency with which these thoughts occur. An additional ATQ

1. Investigate differences in the frequency and strength of belief in
negative cognitions between a group with MDD and controls.
It was predicted that participants with MDD would have higher
frequency and greater strength of belief in negative cognitions.
2. Investigate relationships between negative cognitions, cortisol, and oxytocin. It was predicted that negative cognitions
would be associated with higher cortisol levels and lower
oxytocin levels.
3. Ascertain whether negative cognitions, cortisol, and oxytocin
each account for unique variance in symptoms of major
depressive disorder. It was predicted that negative cognitions
and cortisol levels would positively predict, and oxytocin
concentrations would inversely predict, depressive symptoms.
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and cortisol levels through a proposed mediator (negative
cognitions, measured by the ATQ Total score) using the Process
method (45) and the recommendations of Baron and Kenny (46).
Age was included as a covariate in all regression models. We
hypothesized that stress would be a risk factor for higher cortisol
levels, and that cortisol levels would depend on the extent of
negative cognitions. We tested the following predictions:

scale assesses the strength of belief (1 = not at all, 5 = totally) in
negative thoughts. Because the ATQ assesses thought processes
during the past week, it provides a measure of the state of recent
thinking patterns rather than long-term traits. Additional
psychometric and biometric data were also collected as part of
a larger study of MDD.

Blood Collection and Processing

1. Stress levels would be related to cortisol levels (path c).
2. Stress levels would be related to negative cognitions (path a).
3. When both stress and negative cognitions are entered
simultaneously into the regression equation as predictors of
cortisol, negative cognitions would be related to cortisol (path
b) however stress would no longer predict, or would be
lessened in predicting, cortisol levels (path c′).

All blood samples were taken between 9 and 11 AM. Each
participant gave one blood sample, and collection times were
matched between groups. A phlebotomist drew 8 ml of blood
from a vein in the cubital fossa into tubes with EDTA which were
immediately placed on ice. Aprotinin was added (25 ml/ml
blood) within 5 minutes of collection. Within 20 minutes of
collection, blood was centrifuged at 2800 rpm and 4°C for 10
minutes, after which plasma was aliquoted and stored at −80°C
until analysis. Plasma cortisol and oxytocin were measured using
a standard enzyme linked immunosorbent assay (ELISA)
method with detection at 450 nm. Samples and standards were
run in triplicate. The cortisol and oxytocin assays had a
sensitivity of 2.44 ng/ml and 15 pg/ml, respectively, with intraassay and inter-assay variance of less than 9% and 10%,
respectively for cortisol, and less than 14% and 20%,
respectively for oxytocin.

If results from all three equations were satisﬁed according to
Baron and Kenny's (46) criteria, it would suggest that negative
cognitions affect the relationship between stress and cortisol
levels. Because the indirect effect may not be normally
distributed, the 95% conﬁdence interval (CI) was derived from
bootstrap resampling (50,000). If the CI produced does not cross
zero then criteria for mediation have been met (47).

Statistical Analyses

RESULTS

Prior to analysis, the variables were examined for skewness and
kurtosis and transformed where necessary to better approximate
normal distributions. Z-tests were applied to test for normality
using skewness and kurtosis. Z-scores were obtained by dividing
the skew values or excess kurtosis by their standard errors, using
a critical value of 3.29 for medium-sized samples (n = 50–300), at
which the null hypothesis would be rejected and the distribution
considered non-normal (42, 43).
Two-way group (MDD, control) by Sex (male, female)
ANOVAs were performed to examine the effects and
interactions of clinical status and sex on each study variable.
Pearson correlations were used to assess relationships between
the variables. We conducted preliminary correlational analyses
in each group separately to establish that the correlations
between variables were in the same directions across groups.
Having conﬁrmed this, the main correlational analyses were
conducted across all participants, as the variables were
conceptualized to occur in a continuum in the population, and
power analyses using G*Power 3.1.9.3 (44) indicated that
separate group analyses would be underpowered, as in order to
detect a medium effect size (p = 0.3), with an alpha of 0.05, and a
power of 0.8, a sample size of 84 people is needed.
A multiple regression was performed to ascertain whether
negative cognition, cortisol, and oxytocin were all signiﬁcant
unique predictors of depression scores, while controlling for age
and sex. We tested the extent to which negative thinking (ATQ
Total score), cortisol, and oxytocin levels account for unique
variance in DASS depression score after accounting for
demographic variables.
Next we conducted a mediation analysis to assess the indirect
relationship between stress (measured by the DASS Stress score)
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Participant characteristics and between-group analyses are
presented in Table 1. Blood collection was unsuccessful for
two participants with MDD, hence the ﬁnal data set included
61 participants with MDD and 60 controls. Eight participants
with MDD reported a history of anxiety, one reported a previous
adjustment disorder and one had previous post-traumatic stress
symptoms. The MDD and control groups did not differ
signiﬁcantly on age. The male: female ratio was 25:35 in the
control group and 26:35 in the MDD group. Chronbach's alpha
indicated good-excellent reliability of the psychometric scales
(Table 1). For the psychometric scales, absolute z-scores for
skewness (1.87 to 2.17) and kurtosis (−1.1 to −2.5) were below
the acceptable critical value of 3.29, indicating acceptable
normality. Both hormones were non-normally distributed and
therefore were transformed prior to further analyses. Cortisol
was positively skewed, (kurtosis: 5.3, SE.44; skewness: 1.7, SE
0.22) which improved with log transformation (kurtosis: −0.25,
SE 0.44; skewness: −0.35, SE 0.22). Oxytocin was also positively
skewed (kurtosis: 0.46, SE 0.43; skewness: 0.92, SE 0.22) which
improved with square-root transformation (kurtosis: −0.44, SE
0.43; skewness: −0.23, SE 0.22). Two-way ANOVAs with
diagnostic Group (MDD, control) and sex (female, male) as
between-group factors indicated that there were no signiﬁcant
differences between males and females, and no Sex by Group
interactions for any of the study variables (P > 0.05 in all cases),
hence all further analyses were run with data from both sexes
combined. The MDD group scored signiﬁcantly higher than
controls on the Total ATQ score and each ATQ subscale. The
MDD group had higher Depression and Stress scores, higher
cortisol levels, and lower oxytocin levels than controls (Table 1).
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TABLE 1 | Descriptive data and analyses of variance between participants with MDD (n = 61) and controls (n = 60) for demographic, hormonal, and psychometric
study variables.
Variable

Age
Cortisol
Oxytocin
DASS
ATQ

Years
nmol/L
pg/ml
Depression
Stress
Personal maladjustment and desire for change
Negative self-concepts and negative expectations
Low self-esteem
Helplessness
Total Strength of negative beliefs
ATQ Total frequency of negative beliefs

MDD

Control

Mean (SD)

Mean (SD)

31.8 (14.63)
252.29 (102.63)
158 (140)
22.98 (9.42)
21.51 (9.49)
17.44 (5.52)
21.13
(8.23)
5.52
(2.94)
5.77
(2.18)
89.38
(29.23)
91.43
(30.88)

32.3 (10.98)
106.65 (64.53)
261.7 (158.97)
6.2 (7.4)
10.30 (7.97)
9.35 (4.53)
10.83 (4.93)

Chronbach's alpha

F

p

h2p

0.94
0.89
0.91
0.94

0.04
86.98
14.68
118.42
49.39
77.63
69.36

0.85
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

0.00
0.42
0.11
0.50
0.29
0.40
0.37

0.90

41.83

<0.001

0.26

0.73

45.74

<0.001

0.28

0.98

32.6

<0.001

0.22

0.98

69.16

<0.001

0.38

2.75
(1.57)
3.15
(2.08)
55.88
(35.09)
49.45
(21.35)

DASS, Depression, Anxiety, and Stress Scales; ATQ, Automatic Thoughts Questionnaire.

residuals were considered to be satisﬁed based on the
i n s p e c t i o n of p l o t s o f s t a n d a r d i z e d r e s i d u a l s a n d
predicted values.
Results of the multiple regression analysis investigating the
relative contribution of negative cognitions, cortisol, and
oxytocin as independent predictors of DASS depression are
shown in Table 3. Age, sex, ATQ total score, cortisol, and
oxytocin levels were entered as independent variables, and
collectively the predictors accounted for a signiﬁcant 79% of
the variance in DASS Depression, R2 = 0.79, F (4, 116) = 86.65,
p < 0.001. Age, sex, and oxytocin levels were not signiﬁcant
predictors of Depression score (Table 3). Both ATQ total, b =
0.783, p < 0.001, and cortisol level, b = 0.193, p < 0.001, were
signiﬁcant predictors, each accounting for unique variance in
Depression while other variables were held constant.
Results of the mediation analysis for negative cognitions in
the relationship between stress and cortisol levels are shown in
Table 4 and Figure 1. The results indicate that the critical
conditions for mediation were satisﬁed. 1) Path c was

Preliminary correlational analyses indicated that the direction
of relationships between the variables was similar across groups.
Correlations are therefore reported across both groups (Table 2).
Cortisol was positively correlated with depression, anxiety, stress,
and all scales of the ATQ. Oxytocin was inversely correlated with
depression, stress, ATQ helplessness, personal maladjustment
and desire for change, negative self-concepts and negative
expectations, total strength of negative beliefs, and total
frequency of negative beliefs. Depression correlated positively
with anxiety, stress, and all measures of the ATQ. Additionally,
the subscales of the ATQ were correlated with each other.
Tolerance was greater than 0.10 and variance inﬂation factor
values were all below 3, indicating an absence of
multicollinearity. Mahalanobis distance test identiﬁed seven
multivariate outliers. The regression analyses were run both
with and without the outliers, and the results were equivalent,
hence it was decided to retain the outliers, and results are
reported with the full data set. For the regression analyses, the
assumptions of normality, linearity, and homoscedasticity of

TABLE 2 | Pearson's Correlations for Study Variables.
Variable

1

2

3

4

5

6

7

8

9

10

1. Cortisol
2. Oxytocin
3. DASS Depression
4. DASS Anxiety
5. DASS Stress
6. ATQ Personal maladjustment and desire for change (PMDC)
7. ATQ Negative self-concepts and negative expectations (NSNE)
8. ATQ Low self-esteem (LSE)
9. ATQ Helplessness
10. ATQ Total strength of negative beliefs
11. ATQ Total frequency of negative beliefs

0.07
0.53**
0.39**
0.42**
0.41**
0.43**
0.40**
0.39**
0.34**
0.44**

−0.26**
−0.18
−0.23**
−0.28**
−0.27**
−0.17
−0.23**
−0.18*
−0.27**

0.74**
0.78**
0.82**
0.85**
0.76**
0.77**
0.67**
0.88**

0.78**
0.65**
0.69**
0.63**
0.66**
0.55**
0.71**

0.74**
0.74**
0.64**
0.76**
0.58**
0.78**

0.89**
0.8**
0.81**
0.73**
0.95**

0.86**
0.84**
0.74**
0.97**

0.71**
0.68**
0.88**

0.66**
0.87**

0.77*

DASS, Depression, Anxiety, and Stress Scales; ATQ, Automatic Thoughts Questionnaire.
**Correlation is signiﬁcant at the 0.01 level (two-tailed).
*Correlation is signiﬁcant at the 0.05 level (two-tailed).
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TABLE 3 | Summary of multiple regression analysis predicting depressive
symptoms as measured by DASS Depression scores.
Predictor

B

b

sr2

p

Age
Sex
Total ATQ
Cortisol
Oxytocin

−0.003
0.018
0.270
0.021
−0.103

−0.003
0.001
0.772
0.198
−0.056

<0.001
<0.001
0.386
0.027
<0.001

0.947
0.986
<0.001
<0.001
0.227

psychopathology were higher in participants with MDD than in
controls. Plasma cortisol levels correlated positively with all
aspects of negative thinking, whereas oxytocin showed inverse
correlations with aspects of negative thinking. Cortisol and
negative thinking, but not oxytocin, accounted for unique
variance in depressive symptoms. In addition, we found that
the relationship between stress and cortisol levels depended on
the extent of negative cognitions, a novel ﬁnding in research
investigating psychobiological mechanisms in MDD.
The ﬁnding that participants with MDD reported experiencing
both higher frequency of negative thinking and a greater strength
of belief in negative cognitions than non-depressed controls was as
predicted. Additionally, different domains of negative thinking
were compared and participants with MDD had signiﬁcantly
higher levels of negative thinking across all subtypes, including
personal maladjustment and desire for change, negative selfconcepts and negative expectations, low self-esteem, and
helplessness. This is consistent with previous research in MDD
(48) and is further conﬁrmation of the pervasive and global nature
of negative thinking in depression.
Additionally, as hypothesized, negative cognitions were
signiﬁcantly positively correlated with cortisol levels. This was
the case for all domains of negative cognitions and for both the
frequency of occurrence and strength of belief in negative
cognitions in MDD. Oxytocin was inversely related to thoughts
of helplessness, total strength, and frequency of negative beliefs,
personal maladjustment and desire for change and negative
expectations. The results indicate that both cortisol and
oxytocin levels are related to patterns of negative thinking;
however, the relationships are somewhat broader and stronger
for cortisol than oxytocin. Closer examination of the measure of
negative thinking used in the current study, the ATQ, shows that
few items relate to interpersonal or social aspects of
depressogenic thinking. It would be of interest in future studies
to assess whether interpersonally focussed negative thoughts
have a stronger relationship to oxytocin levels.
We also assessed whether cognitions, cortisol, and oxytocin
accounted for unique variance in depressive symptoms.
Regression analysis indicated that both cognitions and cortisol
accounted for unique variance in depressive symptoms after
accounting for demographic factors. The ﬁndings provide
further information regarding relationships between
physiological aspects of depression and negative thinking, a
prominent psychological feature of MDD. Hypercortisolism is
one of the most consistently reported ﬁndings in research into
the biology aspects of depression (e.g. 49). Additionally,
glucocorticoids are neurotoxic in some circumstances and are
linked to brain morphological changes seen in depression (50).
While an established body of literature has linked cortisol
secretion to impairments in neuropsychological functioning in
MDD (51–53), previous research focussed on emotionally
neutral aspects of cognition in relation to cortisol, such as
concentration, memory, and executive functions. Studies
investigating direct links between cortisol and negative thought
content, the hallmark of MDD, were lacking, although plausible
theoretical models linking the two had been proposed (4). The

ATQ, Automatic Thoughts Questionnaire; DASS, Depression, Anxiety and Stress Scales.

TABLE 4 | Mediation effects of negative cognitions on the relationship between
stress levels and cortisol levels (N = 121).
Path/effect

B

SE

t

p

95% CI
LLCI ULCI

a stress !negative cognitions
b negative cognitions! cortisol
c stress ! cortisol
c' stress ! cortisol controlled for
negative cognitions
(a x b) indirect effect stress !
cortisol, with negative cognitions as a
mediator †

2.49
0.98
4.89
2.44

0.20 12.47 <0.00 2.09
0.43 2.31 0.02 0.14
0.94 5.21 <0.00 3.03
1.40 1.74 0.08 0.34

2.45 1.29

0.12

2.88
1.83
6.75
5.22
5.20

Note: B, unstandardized coefﬁcient; LLCI, low limit conﬁdence interval; ULCI, upper limit
conﬁdence interval.
†Derived from 50,000 bootstrap samples.

signiﬁcant, F (2,118) = 13.56, p < 0.001, R2 = 0.19, indicating that
stress levels signiﬁcantly predicted cortisol levels when ignoring
the mediator (negative cognitions). 2) Path a was also signiﬁcant,
F (2,118) = 88.65, p < 0.001, R2 = 0.60, indicating that stress levels
signiﬁcantly predicted negative cognitions. 3) When both stress
and negative cognitions were entered simultaneously into the
regression equation as predictors of cortisol, the overall model
was signiﬁcant, F (3,117) = 11.16, p < .001, R2 = 0.22. Negative
cognitions predicted cortisol (path b), however stress no longer
predicted cortisol signiﬁcantly (path c′). Therefore the results
from all three equations were satisﬁed according to Baron and
Kenny's (46) criteria, suggesting that negative cognitions have a
mediation relationship between stress and cortisol levels.
Additionally, the bootstrapping analysis with 50 000 resamples
indicated that 95% CI for the indirect effect did not include zero.
The indirect effect is therefore considered signiﬁcant, and
mediation is supported (Table 4). In summary, because there
is evidence of mediation and the direct effect (path c′) is nonsigniﬁcant, we can infer full mediation, in other words that the
relationship between stress and cortisol is fully transmitted
through the mediator, negative cognitions.

DISCUSSION
To our knowledge, this is the ﬁrst study to directly measure
relationships between the frequency and strength of negative
cognitions and either cortisol or oxytocin levels, in individuals
with MDD and controls. Levels of negative thinking, stress, and
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FIGURE 1 | A three-variable mediation model. (A) The direct effect model for stress and cortisol. (B) The mediation model with negative cognitions as a mediator
between stress and cortisol. Standardized path coefﬁcients are shown, with corresponding unstandardized coefﬁcients in parentheses. *P <0.05; **P < 0.01, Ns, Not
signiﬁcant. (P = .13; N = 121).

of cognitive-behavioral approaches to treating emotional
disorders including MDD. The current ﬁndings, however,
provide ﬁrmer evidence of the potential importance of
psychological processes in relation to stress and cortisol levels,
an index of HPA axis activity. There are indications that cortisol
responses to stress predict the course of depression trajectories
(55, 56). This in turn leads to consideration of the potential for
cognitive-behavioral interventions to alter HPA activity through
changing cognitive interpretations of situations. Although it has
been proposed that cortisol could be affected indirectly through
psychotherapeutic approaches (57), there is surprisingly little
research systemmatically investigating effects of psychological
therapy on cortisol levels, and further research is needed.
The current results provide further information about
the close links between cognitive-emotional processing
and biological factors in MDD, supporting an integrated
biopsychosocial model of MDD. In conjunction with previous
imaging research, they suggest that cognitive appraisal may be
linked to the intensity of HPA axis responses and cortisol release.
Cortisol release, in turn, is related to difﬁculties in concentration
and memory, and potential impact on the serotonergic system
and depression (4). Interventions which promote realistic, rather
than negative, cognitive reappraisals may minimise the impact
on HPA axis activity and intercept the initiation, maintenance,
and kindling of depressive episodes and their further

current results provide new information about content-speciﬁc,
depressogenic aspects of cognition, and their relationship to
cortisol levels. Oxytocin did not account for unique variability
in depression symptoms after accounting for the other
independent variables.
Additionally, we conducted a mediation analysis to test direct
and indirect relationships between stress levels, negative
cognitions, and cortisol levels, and to test Beck's (4) hypothesis
that negative cognitions are important in the relationship
between stress and cortisol. This analysis indicated that stress
levels were signiﬁcantly related to cortisol levels when ignoring
the role of negative cognitions, and that stress levels were also
signiﬁcantly related to negative cognitions. However, when
negative cognitions were included as a mediator in the model,
negative cognitions were related to cortisol but stress was no
longer a signiﬁcant predictor of cortisol. The results suggest that
the relationship between stress and cortisol depends on the
extent of negative thinking. To our knowledge, this is the ﬁrst
direct empirical test of relationships between these variables, and
the results appear to be consistent with Beck's (4) hypothesis that
negative cognitions are important in the relationship between
stress and cortisol.
Cognitive appraisals of situations have been recognized since
ancient times as being of importance in determining emotional
reactions to situations (54), and these assumptions form the basis
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supported the hypothesis that the relationship between stress
levels and cortisol levels depended on the extent of negative
cognitive distortions. The results help to support long standing
hypothetical models and have implications for potential
integrated interventions for MDD incorporating cognitive and
physiological approaches.

physiological sequelae. Further research building knowledge of
the interplay between cognitive factors, stress reactivity, and
mood regulation may allow for more tailored interventions
that match treatment approaches to aspects of HPA function
(55, 56). It is also worth considering the potential for universally
delivered cognitive-behavioral preventative strategies to
intervene earlier between life stressors and physiogical
responses and possibly prevent depression (58).
This study has several limitations which need to be
considered. The mediation analysis draws on cross-sectional
data and atemporal relationships do not imply causation (59).
We can conclude that cognitive distortions are uniquely
associated with cortisol levels, and accounting for them
attenuates the relationship between stress and cortisol levels,
when considering the shared relationship among all three
variables (59). Additionally, symptoms and negative thinking
were assessed over the preceding week; consistent with an
assessment of state rather than long-term traits. Longitudinal
or interventional research is needed to examine changes in
hormones in relation to stress and cognitive distortions over
time to conﬁrm temporal relationships between the variables.
Nevertheless, the results provide some of the ﬁrst direct measures
of relationships between negative cognitions and hormonal
measures. We did not assess diurnal variations in cortisol
between the groups in relation to the study variables, however
time of collection was matched between groups. While there
have been studies of diurnal cortisol levels in MDD, further
research is needed to understand whether these interact with
negative thinking. Additionally, future studies integrating data
from brain imaging which also incorporate measures of negative
thinking and cortisol would help to test and further solidify
integrated models of depression. Additional research is also
warranted to better understand relationships between negative
thought content and other aspects of neuropsychological
functioning, such as executive functioning and inhibitory
processes in MDD. Future research examining relationships
between oxytocin and patterns of depressogenic thinking
should also include measures with greater focus on
interpersonal relationships. Additionally, we did not evaluate
previous stressor events or family psychiatric history in the
participants. It may be informative to include such evaluations
in future research.
In conclusion, we found that cortisol levels, and to a lesser
extent oxytocin levels, were related to depressogenic cognitive
distortions. Cortisol and cognitive distortions both accounted for
unique variability in depression symptoms. Mediation analyses
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